Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over studyMario Cozzolino, Andrea Galassi, Lorenza Magagnoli et al.|Clinical Kidney Journal|2019Cited by 50
Future treatment of vascular calcification in chronic kidney diseaseMario Cozzolino, Giuseppe Cianciolo, Federico Maffei Faccioli et al.|Expert Opinion on Pharmacotherapy|2023Cited by 16
Cytokine and Chemokine Retention Profile in COVID-19 Patients with Chronic Kidney DiseasePaola Ciceri, Mario Cozzolino, Valeria Bono et al.|Toxins|2022Cited by 14
Growth Differentiation Factor 15 (GDF-15) Levels Associate with Lower Survival in Chronic Kidney Disease Patients with COVID-19Andrea Galassi, Giulia Marchetti, Paola Ciceri et al.|Biomedicines|2022Cited by 10
Current treatment options for secondary hyperparathyroidism in patients with stage 3 to 4 chronic kidney disease and vitamin D deficiencyAndrea Galassi, Mario Cozzolino, Paola Ciceri et al.|Expert Opinion on Drug Safety|2021Cited by 10